Home › Funds › GREAT POINT PARTNERS LLC › RNTX

GREAT POINT PARTNERS LLC position in RNTX

REIN THERAPEUTICS INC · Health Care

GREAT POINT PARTNERS LLC reported holding 1,663,144 shares of RNTX (REIN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.33% of its reported portfolio and ranking #40 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed RNTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.66M sh
Reported value held$1.34M
Portfolio Weight0.33%
First reportedQ2 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How GREAT POINT PARTNERS LLC's RNTX position evolved

GREAT POINT PARTNERS LLC first disclosed a stake in RNTX in Q2 2026 at 2,575,000 shares (US$2.7M). Across 2 filings, GREAT POINT PARTNERS LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,663,144 shares valued at US$1.3M — a reduction of -911,856 shares quarter over quarter.. Notable position changes include a 35% trim in Q3 2026 (shares fell 50% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 2.58M $2.68M New
Q3 2026 1.66M $1.34M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RNTX and 13F data

RNTX (REIN THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in RNTX — the largest reported positions include BIOS Capital Management, LP (US$2.40B), Voss Capital, LP (US$4.7M), Cable Car Capital, LP (US$4.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RNTX

All RNTX fund holders →

FAQ

How long has GREAT POINT PARTNERS LLC held RNTX?

GREAT POINT PARTNERS LLC has disclosed RNTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is GREAT POINT PARTNERS LLC's current position in RNTX?

As of Q3 2026, GREAT POINT PARTNERS LLC holds 1.66M shares of RNTX (REIN THERAPEUTICS INC), valued at $1.34M, representing 0.33% of its reported portfolio and ranking #40.

Has GREAT POINT PARTNERS LLC been buying or selling RNTX?

In the latest 13F filing (Q3 2026), GREAT POINT PARTNERS LLC reduced its position in RNTX.

Which other funds hold RNTX?

Other major institutional holders of RNTX include BIOS Capital Management, LP, Voss Capital, LP, Cable Car Capital, LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.